Vogenx, Inc. VOGX
19.69 USD -0.85 (-4.12%)
Nov 4, 2026, 3:33 PM EST
19.22 Day range 21.52
13.00 52-week range 34.13
- YTD
- +51.42%
- 1 year
- +51.42%
- Market cap
- 292.42M
- EPS (ttm)
- -0.22
- YTD return
- +51.42%
- 1-year return
- +51.42%
- Volume
- 119.66K
- Avg volume
- 159.09K
- Open
- 20.30
- Previous close
- 20.53
- Day's range
- 19.22 – 21.52
- 52-week range
- 13.00 – 34.13
2Y +6.49 (+49.92%)
Financials — quick view
VOGX Revenue — quarterly 0
VOGX Net income — quarterly -384.43K
VOGX EPS — quarterly -0.07
News
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
Why QuantumScape Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket 
12 Health Care Stocks Moving In Wednesday's After-Market Session 
Vogenx Initiates EMERGE, Phase 2b Clinical Trial Evaluating Mizagliflozin For Treatment Of Post-Bariatric Hypoglycemia 
Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia 
Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer - 12 Health Care Stocks Moving In Thursday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
Vogenx Appoints Ken Toombs to Board of Directors 
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
Your note
Sign in to keep a note on VOGX — it syncs with the Stock Master app.